Shares of Maryland-based MacroGenics fell by nearly 20% Tuesday after its experimental drug for advanced breast cancer showed only a "modest" impact on delaying tumo...

PHILADELPHIA — The Food and Drug Administration is "open for business" in considering real-world evidence to clear expanded uses of new cancer drugs, acting agency h...

The series C cash will also fund a phase 1 trial in idiopathic pulmonary fibrosis. (Pixabay) Lung Therapeutics has raised a $36 million series C round to take a ...

Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new i...

Cancer drugs are often approved quickly by the Food and Drug Administration. In many cases, however, initial evidence of efficacy is never confirmed by studies testi...